https://www.selleckchem.com/products/nms-873.html
Sentinel lymph node (SLN) mapping was considered for treating endometrial cancer (EC) which was apparent confined to the uterus. Nevertheless, intermediate-high-risk EC patients have super high risk to undergo isolated para-aortic lymph node metastases comparing with low-risk patients. Therefore, this investigation aimed to compare the efficacy of two SLN methods in detecting para-aortic lymph node metastases. According to SLN mapping injection methods, intermediate-high-risk EC patients who received both SLN mapping and systematic lymp
Like
Comment
Share
